CAMBRIDGE, Mass.– Today Firefly BioWorks announced the election of Victor R. Ambros, Ph.D. to the company’s Scientific Advisory Board. Dr. Ambros is the Silverman Professor of Natural Sciences in the Program in Molecular Medicine at the University of Massachusetts Medical School, and serves as co-director of the RNA Therapeutics Institute at UMass Medical. His laboratory […]
MILFORD, Mass. — Waters Corporation (NYSE:WAT) reported today second quarter 2012 sales of $451 million, an increase of 1% over sales of $448 million in the second quarter of 2011. Foreign currency translation decreased sales growth by 3%. On a GAAP basis, earnings per diluted share (E.P.S.) for the second quarter were $1.09 compared to […]
SwitchGear Genomics Inc., a leading provider of products for studying the regulatory elements in the human genome, today announced the launch of a new service group for custom cloning and mutagenesis. These services will provide customers new ways to access the LightSwitch Luciferase Assay System™, a comprehensive reporter assay platform for studying transcriptional and post-transcriptional […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the second quarter of 2012. Second quarter 2012 results: • Revenue of $281 million, a 2% decrease compared to $287 million in the second quarter of 2011. • GAAP net income for the quarter of $23 million, or $0.18 per diluted share, compared […]
Golden, Colorado —— Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced an expanded relationship with a key distributor of its stem cell-based products, privately-held Neuromics, Inc (www.neuromics.com). Vitro Biopharma officials recently met Neuromics principals at their corporate headquarters in Minneapolis, MN. Neuromics was formed in 2005 by Pete Shuster, a marketing and sales professional […]
Hercules, CA and Austin, TX —— Bio Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, and Myriad RBM, Inc., a wholly owned subsidiary of Myriad Genetics Inc. (NASDAQ: MYGN), and a leading multiplex biomarker testing company, today announced that they have partnered to […]
ST. PAUL, Minn.– Today, 3M Food Safety announced that it received AOAC-PTM Certification (#071202) for its new 3M™ Molecular Detection Assay for E. coli O157 (including H7) from the AOAC Research Institute’s Performance Tested MethodsSM Program. The certification gives food processors greater assurance in safeguarding against pathogenic E. coli, a causative agent of foodborne illness […]
HIGHLIGHTS: Q2 2012 Results (all percentages are to comparable periods in 2011) • Q2 2012 reported sales increased 4% to $664 million. Q2 2012 overall sales grew organically by 3% with Research and Sigma-Aldrich Fine Chemicals (“SAFC”) organic sales growth of 1% and 8%, respectively. Acquisitions contributed 6% to sales growth. Changes in foreign currency […]
MOUNTAIN VIEW and REDWOOD CITY, Calif. —— Complete Genomics Inc. (NASDAQ: GNOM) and Ingenuity® Systems Inc. today announced that Complete Genomics will bundle the Ingenuity Variant Analysis application with its research whole genome sequencing services. This bundled solution will enable research customers to rapidly analyze and interpret biologically relevant genetic variations and provide researchers with […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced pricing for BaseSpace, the Company’s genomics cloud computing and storage platform. The flexible pricing structure will allow researchers around the world to take advantage of BaseSpace’s industry-leading data storage, analysis, and sharing capabilities. Every BaseSpace account will now include 1 terabyte (TB) of free storage for Illumina […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
